Interview with John Dawson, Founder & CEO, Alliance Pharma plc
Today, Alliance Pharma Plc. represents a true pharmaceutical success story in the UK, distributing to 24 countries…
Alliance Pharma Plc
Last updated: 13.02.2014
Address: Avonbridge House, Bath Road, Chippenham, Wiltshire SN15 2BB, United Kingdom ,United Kingdom
Tel: +44 (0)1249 466966
Web: http://www.camb-labs.com/default.asp
Company description
Alliance is a speciality pharmaceutical group based in the United Kingdom and listed on AIM. The group was founded in 1998 and since then has established a strong track record of acquiring the rights to established niche products. Alliance now owns or licences over 50 prescription products. Pro forma annual sales now exceed £40m.
Alliance maintains strategic and controlling functions with a management team possessing considerable large pharmaceutical company experience. More labour and capital intensive functions are outsourced to maximise efficiency and profitability.
The core of Alliances’ activities are in the United Kingdom and the Republic of Ireland. The group also sells into approximately 20 other countries Worldwide, including via a joint venture into China.
Products and services
Anti Infective, Cough, Cold & Flu
Cardiovascular
Central Nervous System
Dental
Dermatology
Diagnostics
Nutrition
Obstetrics & Gynaecology
Rheumatology
Toxicology
Oncology
Endocrinology
Interviews
Related
Amryt: A Rare Disease Startup Going Global
Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial…
HIV ‘Cure’ on the Horizon? London Patient Cleared of AIDS Virus
Hopes have been raised of a cure for AIDS after a patient in London became free of the HIV virus following a bone…
Company Profile: GW Pharmaceuticals
Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
The UK to Incentivise Big Pharma Firms to Develop New Antibiotics
In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on…
The 5 Most Influential Medical Research Charities in the UK
An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of…
GSK and Pfizer Consumer Health Divisions to Merge
The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint…
The Line Manager of Tomorrow
Ian Chamberlain looks at the changing role of the pharma sales manager and the skills needed to keep up with new…
Nationalism & Populism: A Roadblock for Global Pharma
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom,…
The Changing Role of the Medical Rep
With more than 25 years pharmaceutical industry experience, Ian Chamberlain provides training to help pharma…
Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
The UK will add folic acid to flour to reduce defects in newborns
The UK Prime Minister has been convinced by medical professionals to fortify all flour with folic acid to reduce…
